(Q72643912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Combination chemotherapy for stage IV Hodgkin's disease (Report no 14) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Combination chemotherapy for Stage IV Hodgkin's disease (report no 14) (English)

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(81)80182-1

19 August 2023

1 reference

J. M. Goldman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6168426

19 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6168426

19 August 2023

publication date

1 September 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:S0009926081801821?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(81)80182-1

https://api.elsevier.com/content/article/PII:S0009926081801821?httpAccept=text/plain

19 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(81)80182-1

19 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

531-536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Combination therapy for advanced resistant Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Prednisone in MOPP chemotherapy for Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

A comparative study of a bcnu containing 4-drug program versus mopp versus 3-drug combinations in advanced Hodgkin's disease.A cooperative study by the cancer and leukemia group B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Maintenance chemotherapy for advanced Hodgkin's disease in remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9260%2881%2980182-1

Report of the Committee on Hodgkin's Disease Staging Classification

7 January 2021

series ordinal

4

1 reference

https://api.crossref.org/works/10.1016/S0009-9260(81)80182-1

19 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6168426%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference